NM_018685.5:c.140C>G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_018685.5(ANLN):c.140C>G(p.Ala47Gly) variant causes a missense change. The variant allele was found at a frequency of 0.0000445 in 1,596,190 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_018685.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANLN | NM_018685.5 | c.140C>G | p.Ala47Gly | missense_variant | Exon 2 of 24 | ENST00000265748.7 | NP_061155.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANLN | ENST00000265748.7 | c.140C>G | p.Ala47Gly | missense_variant | Exon 2 of 24 | 1 | NM_018685.5 | ENSP00000265748.2 | ||
ANLN | ENST00000396068.6 | c.140C>G | p.Ala47Gly | missense_variant | Exon 2 of 23 | 1 | ENSP00000379380.2 | |||
ANLN | ENST00000424865.1 | c.74C>G | p.Ala25Gly | missense_variant | Exon 2 of 4 | 3 | ENSP00000404979.1 | |||
ANLN | ENST00000418118.1 | c.74C>G | p.Ala25Gly | missense_variant | Exon 2 of 2 | 3 | ENSP00000406584.1 |
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152172Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000441 AC: 11AN: 249218Hom.: 0 AF XY: 0.0000297 AC XY: 4AN XY: 134752
GnomAD4 exome AF: 0.0000270 AC: 39AN: 1444018Hom.: 0 Cov.: 30 AF XY: 0.0000209 AC XY: 15AN XY: 716690
GnomAD4 genome AF: 0.000210 AC: 32AN: 152172Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74344
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.140C>G (p.A47G) alteration is located in exon 2 (coding exon 2) of the ANLN gene. This alteration results from a C to G substitution at nucleotide position 140, causing the alanine (A) at amino acid position 47 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
ClinVar contains an entry for this variant (Variation ID: 1437192). This variant has not been reported in the literature in individuals affected with ANLN-related conditions. This variant is present in population databases (rs35765596, gnomAD 0.08%), and has an allele count higher than expected for a pathogenic variant. This sequence change replaces alanine, which is neutral and non-polar, with glycine, which is neutral and non-polar, at codon 47 of the ANLN protein (p.Ala47Gly). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
ANLN-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at